Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NSE - Delayed Quote INR

Niva Bupa Health Insurance Company Limited (NIVABUPA.NS)

Compare
72.01
+0.94
+(1.32%)
At close: 3:30:02 PM GMT+5:30
Loading Chart for NIVABUPA.NS
  • Previous Close 71.07
  • Open 71.94
  • Bid --
  • Ask --
  • Day's Range 71.15 - 72.25
  • 52 Week Range 69.21 - 109.34
  • Volume 824,487
  • Avg. Volume 1,805,719
  • Market Cap (intraday) 131.564B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 80.01
  • EPS (TTM) 0.90
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 76.00

Niva Bupa Health Insurance Company Limited provides health insurance products in India. It underwrites individual and family health, critical illness, and personal accident insurance plans, as well as travel insurance. Niva Bupa Health Insurance Company Limited was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Health Insurance Company Limited in July 2021. The company was founded in 1947 and is based in Gurugram, India. Niva Bupa Health Insurance Company Limited operates as a subsidiary of Bupa Singapore Holdings Pte. Ltd.

www.nivabupa.com

8,876

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NIVABUPA.NS

View More

Performance Overview: NIVABUPA.NS

Trailing total returns as of 3/12/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX .

YTD Return

NIVABUPA.NS
14.39%
S&P BSE SENSEX
5.26%

1-Year Return

NIVABUPA.NS
7.84%
S&P BSE SENSEX
0.49%

3-Year Return

NIVABUPA.NS
7.84%
S&P BSE SENSEX
33.27%

5-Year Return

NIVABUPA.NS
7.84%
S&P BSE SENSEX
125.85%

Compare To: NIVABUPA.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NIVABUPA.NS

View More

Valuation Measures

Annual
As of 3/11/2025
  • Market Cap

    129.85B

  • Enterprise Value

    128.83B

  • Trailing P/E

    78.93

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.66

  • Price/Book (mrq)

    4.01

  • Enterprise Value/Revenue

    2.64

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.12%

  • Return on Assets (ttm)

    1.50%

  • Return on Equity (ttm)

    4.86%

  • Revenue (ttm)

    52.74B

  • Net Income Avi to Common (ttm)

    1.65B

  • Diluted EPS (ttm)

    0.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.5B

  • Total Debt/Equity (mrq)

    6.59%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NIVABUPA.NS

View More

Company Insights: NIVABUPA.NS

Research Reports: NIVABUPA.NS

View More

People Also Watch